Sperimentazione clinica dietetica culturalmente adattata in PR (PRECISION)
Sperimentazione clinica dietetica culturalmente adattata in PR: valutazione di Porto Rico di un intervento sostenibile culturalmente informato per un'alimentazione ottimale (PRECISIONE)
This project will determine whether a diet culturally adapted to adults in Puerto Rico can effectively decrease cardiometabolic risk factors. This will help define a culturally-appropriate, feasible, and sustainable diet intervention aimed at reducing cardiovascular, type 2 diabetes, and obesity outcomes.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
This intervention will culturally tailor a diet to the adult population in Puerto Rico based on staple foods as well as culturally appropriate strategies to reduce cardiometabolic risk factors. Based on preliminary results from studies on the island, investigators will conduct a 24-month, 2-arm intervention among 250-350 adults (125-175 per arm) ages 30-65 living in Puerto Rico with at least 1 of 5 cardiometabolic risk factors. The two arms are (1) intervention group with culturally-tailored portion-control Mediterranean Diet-like advice through monthly individual counseling for 12 months, reinforced with daily text messages for 12 months, and a monthly household supply of legumes, vegetable oils, and locally sourced assorted fruit and vegetables for 18 months; (2) control arm with portion-control standard non-tailored nutritional counseling in monthly individual sessions for 12 months, reinforced with daily text messages for 12 months, and monthly assistance to purchase healthy foods for 18 months. From months 18-24, we will monitor behavior maintenance (no food/voucher or counseling), with support from the nutritionist, and cues-to-action texts. Investigators will measure changes in cardiometabolic risk factors and metrics of eating behaviors and psychological factors. The two co-primary outcomes are changes in ASCVD score and cardiometabolic improvement score.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Natalia Torres, BS
- Numero di telefono: 787-523-1593
- Email: natalia.torres@prcci.org
Luoghi di studio
-
-
-
San Juan, Porto Rico, 00926
- Reclutamento
- Puerto Rico Consortium for Clinical Investigation
-
Contatto:
- Natalia Torres, BS
- Numero di telefono: 787-523-1593
- Email: natalia.torres@prcci.org
-
Sub-investigatore:
- Amarilys F Sylva, PhD
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
-
Age 30-65y old at the time of enrollment
-
Non-institutionalized
-
Living in PR at the time of recruitment and for at least the previous year and not planning to move from the island within the next 3 years
-
Able to answer questions without assistance
-
Having a cellphone with the capacity to receive text messages and be willing to receive daily text messages from the study on the designated cellphone number
-
Having at least one of the following:
- elevated BMI
- elevated waist circumference
- self-reported physician-diagnosed hypertension or use of hypertension medication or measured high blood pressure at the baseline visit
- self-reported physician-diagnosed pre-diabetes or measured pre-diabetes at the baseline visit
- self-reported physician-diagnosed dyslipidemia or use of lipid-lowering agents or laboratory values confirming dyslipidemia
Exclusion Criteria:
- Under 30 or over 65 years of age (on the day of the interview).
- Currently not living in Puerto Rico or not lived on the island for at least 1 year or planning to move within 3 years
- Institutionalized
- Not able to answer questions without assistance
- Not having at least 1 of the five listed metabolic criteria
- Self-reported physician-diagnosed type 1 or type 2 diabetes or use of diabetes medication (including insulin) or diabetes-diagnosis values confirmed by laboratory
- Self-reported pregnancy
- Gastrointestinal or chronic condition that would impact eating behaviors or nutritional status
- Intolerance or allergies to legumes (i.e.: beans and nuts), vegetable oils (i.e.: corn, olive, canola), or fresh produce
- Living with another person participating in the study
- Participating in another research study that conflicts with PRECISION
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Triplicare
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Intervention
Intervention group will receive culturally-tailored portion-control Mediterranean-like advice through monthly individual counseling for 6 months, reinforced with daily text messages for 12 months, and a monthly household supply of legumes (i.e., beans and peanuts), vegetable oils (i.e., olive oil + a blend of canola and soybean), and locally sourced assorted fruit and vegetables for 18 months. From months 18 to 24, we will monitor maintenance of behavior (no food or counseling) with support from the nutritionist available. |
Puerto Rico-tailored education includes strategies for healthy eating, preferences for traditional healthy foods, recommendations for limiting unhealthy traditional foods, portion sizes, etc. |
|
Comparatore attivo: Control
Control group will receive portion-control standard non-tailored nutritional counseling in monthly individual sessions for 6 months, reinforced with daily text messages for 12 months, and monthly assistance to purchase healthy foods for 18 months. From months 18 to 24, we will monitor maintenance of behavior (no voucher or counseling), with support from the nutritionist available. |
Standard healthy eating education includes strategies, foods, portions, and cooking and eating tips included in the My Plate For A Healthy Puerto Rico dietary recommendations. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
10-year risk score for a first atherosclerotic CVD event (ASCVD score)
Lasso di tempo: 6; 12; 18; 24 months
|
Estimate the change in first atherosclerotic CVD event (ASCVD) score; the score is calculated using the Pooled Cohort Equation which accounts for biological sex, age, race, total cholesterol, HDL-C, systolic blood pressure, treatment for high blood pressure, current diabetes diagnosis, and smoking status. Scores are expressed as percentage (0-100) with higher scores indicative of higher 10-year risk for ASCVD event. It is categorized as low-risk <5%; borderline risk 5% to 7.4%; intermediate risk 7.5% to 19.9%; and high risk ≥20%. |
6; 12; 18; 24 months
|
|
Cardiometabolic Improvement Score (CIS)
Lasso di tempo: 6; 12; 18; 24 months
|
Estimate the change in the score; calculated as the added number of risk factors changed over a predefined value; range of 0 to 10; from less to more improvement. |
6; 12; 18; 24 months
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Changes in diet quality score
Lasso di tempo: 6; 12; 18; 24 months
|
Determine the change in score of short diet quality screener (range 18-54; from lowest to highest quality) |
6; 12; 18; 24 months
|
|
Changes in diet satisfaction: diet satisfaction scale
Lasso di tempo: 6; 12; 18; 24 months
|
Determine the change in the score of the Diet Satisfaction Questionnaire (DSat-45) (range 45-225; from lowest to highest satisfaction) and its summed seven subscales (ranges 5-40) |
6; 12; 18; 24 months
|
|
Changes in intake of pre-specified food groups (fruit; vegetables; legumes; oils; meat; fat)
Lasso di tempo: 6; 12; 18; 24 months
|
Determine the change in servings/week of food groups |
6; 12; 18; 24 months
|
|
Change in levels of waist circumference
Lasso di tempo: 6; 12; 18; 24 months
|
Estimate the change in the value of waist circumference (cm) |
6; 12; 18; 24 months
|
|
Change in levels of BMI
Lasso di tempo: 6; 12; 18; 24 months
|
Estimate the change in the value of body mass index (kg/m2) |
6; 12; 18; 24 months
|
|
Change in levels of blood pressure risk factors
Lasso di tempo: 6; 12; 18; 24 months
|
Estimate the change in the value of systolic and diastolic blood pressure (mmHg) |
6; 12; 18; 24 months
|
|
Change in levels of metabolic risk factors
Lasso di tempo: 6; 12; 18; 24 months
|
Estimate the change in the value of glucose, triglycerides, total cholesterol, LDL, HDL (mg/dL) |
6; 12; 18; 24 months
|
|
Change in food security status
Lasso di tempo: 6; 12; 18; 24 months
|
Estimate the change in food security status assessed by the USDA Food Security Module |
6; 12; 18; 24 months
|
|
Change in self-efficacy score
Lasso di tempo: 6; 12; 18; 24 months
|
Estimate the change in self-efficacy score assessed by the Nutritional Self-Efficacy Scale |
6; 12; 18; 24 months
|
Altre misure di risultato
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in social connectedness score
Lasso di tempo: 6; 12; 18; 24 months
|
Estimate the change in social connectedness score from the Social Connectedness Scale/Social Assurance Scale |
6; 12; 18; 24 months
|
|
Change in social support score
Lasso di tempo: 6; 12; 18; 24 months
|
Estimate the change in social support score from the 12-item Social Support Scale |
6; 12; 18; 24 months
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Investigatori
Investigatori
- Investigatore principale: Josiemer Mattei, PhD, MPH, Harvard Chan School of Public Health
- Direttore dello studio: Amarilys F Sylva, PhD, Puerto Rico Consortium for Clinical Investigations
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
- Malattie del sistema endocrino
- Malattie vascolari
- Malattia cardiovascolare
- Disturbi della nutrizione
- Malattie metaboliche
- Ipernutrizione
- Peso corporeo
- Disturbi del metabolismo del glucosio
- Diabete mellito
- Sovrappeso
- Iperlipidemie
- Disturbi del metabolismo lipidico
- Condizioni patologiche, segni e sintomi
- Malattie nutrizionali e metaboliche
- Segni e sintomi
- Obesità
- Ipertensione
- Diabete mellito, tipo 2
- Iperglicemia
- Dislipidemie
- Ipertrigliceridemia
- Obesità, addominale
- Qualità, accesso e valutazione dell'assistenza sanitaria
- Tecniche investigative
- Metodi epidemiologici
- Raccolta dei dati
- Meccanismi di valutazione dell'assistenza sanitaria
- Qualità dell'assistenza sanitaria
- Sanità pubblica
- Ambiente e salute pubblica
- Misurazioni epidemiologiche
- Valutazione nutrizionale
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- IRB23-0951
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
IPD will be managed and distributed observing NIH and IRB policies on the dissemination and sharing of research results. Study information and requests for data will be available immediately upon the data being de-identified and properly revised for quality control by contacting study investigators.
Periodo di condivisione IPD
10 years
Criteri di accesso alla condivisione IPD
The requested data will be shared with investigators via a secured, password-protected software website, upon request.
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- ICF
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .